SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
Viral Rebound
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
7 of
7
|
Session Overview - Viral Rebound
Javier Martinez-Picado
IrsiCaixa Institute for AIDS Research, Badalona, Spain
Common T-Cell Features Predicting Time to Rebound in Interventional and Non-Interventional Treatment (ABSTRACT
484)
Tongcui Ma
Gladstone Institutes, San Francisco, CA, USA
The Fraction of HIV Reservoir Variants Neutralized by Autologous IgG Correlates With Time to Rebound (ABSTRACT
482)
Mauro A. Garcia
The Johns Hopkins University, Baltimore, MD, USA
Intact HIV Reservoir Levels Are Stable After Short-Term ART Interruption (ABSTRACT
487)
Prerana Shrestha
Brigham and Women's Hospital, Boston, MA, USA
Dynamics of the Intact HIV Reservoir During ART Following Analytical Treatment Interruption (ABSTRACT
485)
Maegan R. Manning
National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
Immune Responses and HIV Reservoir Evolution From Pre-ART to 5 Years Into Post-Treatment Control (ABSTRACT
486)
Leah Carrere
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
Discussion with Audience Questions and Answers
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
7 of
7
|
